Xiang-xin Chen

Xiang-xin Chen


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
WWwei wu
wei wu
XLXunzhi Liu
Xunzhi Liu
QZqi zhu
qi zhu
XCXiang-xin Chen
Xiang-xin Chen
BSBin Sheng
Bin Sheng
CHChunhua Hang
Chunhua Hang
Background: Aneurysmal subarachnoid hemorrhage (aSAH) is a severe neurological event with limited treatment options, and little is known about its pathophysiology. There are few objective tools for predicting outcomes of aSAH patients and further aiding in directing clinical therapeutic programs. This study aimed to determine whether an elevated serum D-dimer/albumin ratio (DAR) reflects disease severity and predicts aSAH outcomes. Methods: We included 178 patients with aSAH. Data included demographics; clinical severity of aSAH (World Federation of Neurological Societies (WFNS) grade and Hunt–Hess grade); levels of D-dimer, albumin, and c-reactive protein (CRP); leukocyte counts on admission; and three-month outcomes. The outcomes were dichotomized into good and poor. The predictive ability of DAR for outcomes was determined using receiver operating characteristic (ROC) curve analysis. Results: Serum DAR showed a positive correlation with disease severity. Univariate analysis revealed that DAR, WFNS grade, Hunt–Hess grade, delayed cerebral infarction (DCI), age, neutrophil-to-lymphocyte ratio (NLR), and CRP/albumin ratio (CAR) were associated with unfavorable outcomes. Multivariate regression analysis further revealed that elevated DAR predicted poor outcomes after adjusting for WFNS grade, Hunt–Hess grade, DCI, age, NLR, and CRP/albumin ratio. Receiver operating characteristic curve analysis revealed that DAR predicted outcomes at a level comparable with NLR and CAR and had superior predictivity than D-dimer alone. Conclusion: DAR is a promising objective tool for aSAH outcome prediction. A high content DAR was associated with disease severity and unfavorable short-term outcomes.

8 May 2025 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
JZJingyuan Zhou
Jingyuan Zhou
FHFangbo Hu
Fangbo Hu
THTaotao Hu
Taotao Hu
YZYikun Zhao
Yikun Zhao
YPYunsong Pan
Yunsong Pan
XCXiang-xin Chen
Xiang-xin Chen

23 August 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
CPCong Pang
Cong Pang
SGSen Gao
Sen Gao
XLxunzhi Liu
xunzhi Liu
XLXiao-Jian Li
Xiao-Jian Li
ZPZheng Peng
Zheng Peng
CHChun-Hua Hang
Chun-Hua Hang
Endogenous host-derived molecules named damage-associated molecular patterns (DAMPs) can induce excessive non-sterile inflammatory responses on recognition of specific membrane-tethered receptors. Here in this study, we aimed to explore the role of DAMP molecule HMGB1 in astrocyte-mediated sterile neuroinflammation and the resultant influences on neurons. In vitro cultured astrocytes were challenged with rHMGB1 and then harvested at 6 h, 12 h, 24 h, 36 h, and 48 h, respectively. The astrocytic CD24 expression was determined by quantitative real-time polymerase chain reaction (qPCR), Western blot analysis and immunofluorescence, nuclear factor kappa B (NF-κB) binding activity was detected by electrophoretic mobility shift assay (EMSA), and the proinflammatory factors, tumor necrosis factor-α (TNF-α), and interleukin 1β (IL-1β), were measured by qPCR. The neuronal morphology was assessed with phase-contrast microscopy. The results showed that astrocytic mRNA and protein CD24 expression began to rise at 24 h, peaked at 36 h, and remained elevated at 48 h after rHMGB1 stimulation, accompanied with enhanced NF-κB binding activity and augmented expression of TNF-α and IL-1β. Furthermore, rHMGB1 caused cocultured neuron damage and was aggregated upon CD24 knockdown. Taken together, these novel findings suggested that rHMGB1 could promote astrocytic CD24 expression, the inhibition of which could aggregate neuronal damage.

22 April 2025 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
YWYu-Hui Wan
Yu-Hui Wan
ZCZeng-Jing Cheng
Zeng-Jing Cheng
LFLing-Xiang Fan
Ling-Xiang Fan
DYDe-Hong Yang
De-Hong Yang
BCBing-Lin Chen
Bing-Lin Chen
QZQing Zhu
Qing Zhu